The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers for Disease Read more
Tag: Biotechnology
COVID subvariant dominant in northeastern U.S. has a growth advantage and may have greater ability to evade immunity than earlier strains, WHO says
The XBB.1.5 omicron subvariant has a growth advantage over other circulating subvariants of the virus that causes COVID-19, and early data suggest it also has a greater ability to evade Read more
China stops issuing visas to Japanese and South Korean visitors as spat over test mandates for Chinese tourists widens
China stopped issuing visas for visitors from Japan and South Korea on Tuesday in apparent retaliation for COVID-testing measures imposed on travelers from China, the Associated Press reported. China had warned Read more
China takes first steps to punish countries that imposed testing mandates for Chinese travelers
China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the Associated Press Read more
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
Ocugen stock up 16% premarket after company announced positive results for its COVID vaccine
Ocugen Inc. stock OCGN, +0.78% rallied 16% in premarket trade Monday, after the biopharma company announced positive results in a trial of its COVID vaccine Covaxin. The Phase 2/3 trial Read more
China’s latest COVID challenge: Lunar New Year holiday travel surge
China is hoping to avoid an acceleration in the pace of new COVID cases during the coming Lunar New Year holiday, when Chinese people traditionally travel home to see family, Read more
WHO is ‘concerned’ about coronavirus variant XBB.1.5 and its apparent growth advantage
The global tally of COVID cases rose 25% in the period stretching from Dec. 5 to Jan. 1 to more than 14.5 million, the World Health Organization said Thursday. Known Read more
As EU works to coordinate response to China’s COVID wave, Beijing and airlines are unhappy
European Union officials were working Wednesday to coordinate a response to China’s current surge of COVID cases and were likely to agree on travel restrictions that may upset both Beijing Read more
New omicron subvariant has become dominant in U.S., climbing to about 41% of cases from 1.3% at the start of December
XBB.1.5 accounted for 40.5% of all cases in the week through Dec. 31, outstripping the two former dominant strains, BQ.1.1 and BQ.1. The former accounted for 26.9% of cases, while Read more